A generic alternative indicated for Neurology. It replaces dopamine levels in the brain to facilitate motor control and reduce tremors associated with neurological movement.
A triple-combination therapy developed to manage Parkinson's symptoms and designed to alleviate 'off' periods by supporting steady brain dopamine levels.
Mechanism of Action
Levodopa replaces dopamine. Carbidopa prevents peripheral breakdown. Entacapone inhibits COMT enzymes, which allows more levodopa to reach the brain and last longer.
Route of Administration
Oral
Onset Time
30–60 minutes
Duration
3–5 hours
Contraindications
Narrow-angle glaucoma, History of melanoma, Use of non-selective MAOIs, Pheochromocytoma
Information for Stalevo is sourced from established medical standards and updated frequently. It is provided for general reference and should be confirmed with a healthcare professional before use.